Phendimetrazine behaves as a sympathomimetic amine and is used as an appetite suppressant.1 We present a case of central retinal vein occlusion (CRVO) that developed after taking phendimetrazine for 2 days. The purpose of this case report is to draw attention to the potential for sight-threatening complications in patients receiving phendimetrazinen, although the event could have been coincidental to its use.
Cho AR, Yoon YH. Central Retinal Vein Occlusion Noted 2 Days After Use of Phendimetrazine as an Appetite Suppressant. JAMA Ophthalmol. 2016;134(4):463–464. doi:10.1001/jamaophthalmol.2015.5966
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: